Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
European Academy of Dermatology and Venereology (EADV) 2021 Annual Meeting
September 29 - October 01, 2021; Virtual
September 29 - October 01, 2021Virtual
Ruxolitinib Cream Meets Endpoints in Phase 3 Vitiligo TrialA topical formulation of the JAK inhibitor ruxolitinib produced statistically significant improvement in all primary and secondary outcomes relative to vehicle alone at 24 weeks.
No Lab Monitoring Needed in Adolescents on DupilumaThese reassuring results confirm that, as previously established in adults, no blood monitoring is required in adolescents
on the monoclonal antibody, which inhibits signaling of interleukins-4 and -13.
Medscape Medical News, Nov 03, 2020
Who's at Risk for Depression on Isotretinoin?A past history of depressive illness conferred a sevenfold increased risk of developing treatment-limiting mood symptoms in
patients on isotretinoin for acne.
Medscape Medical News, Nov 06, 2020
Tildrakizumab for Psoriasis Shows Durable Efficacy Over 5 YearsThe full 5-year results of a study of tildrakizumab for psoriasis show a high rate of sustained disease control coupled with
a favorable safety profile during more than 5400 patient-years of follow-up.
